Back to search

Article

Vigabatrin for SCN2A R853Q Variant-Associated Infantile Epilepsy Spasms Syndrome: Limited Efficacy and Increased Risk of Vigabatrin-Associated Brain Abnormalities on MRI

2026-08-28

Abstract excerpt

<title>Abstract</title> <p> Background Infantile epilepsy spasms syndrome (IESS) caused by the <italic>SCN2A</italic> R853Q loss-of-function (LOF) mutation is refractory or resistant. Vigabatrin (VGB) is a common treatment for IESS, but it carries a risk of Vigabatrin-Associated Brain Abnormalities on MRI (VABAM). This study investigates the efficacy and safety of VGB in infants with IESS caused by the <ital...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0c709dad-132c-55ae-91a2-4cd832677cf4
DOI
10.21203/rs.3.rs-10599141/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Vigabatrin for SCN2A R853Q Variant-Associated Infantile Epilepsy Spasms Syndrome: Limited Efficacy and Increased Risk of Vigabatrin-Associated Brain Abnormalities on MRIDOI 10.21203/rs.3.rs-10599141/v1
Select a neighboring publication to make it the new centre.